Latest news and insights on the pharmaceutical industry | Indian Pharma Post | Page 2

Results For "ED"

10616 News Found

CARBOGEN AMCIS Shanghai site clears unannounced NMPA GMP inspection
News | May 07, 2026

CARBOGEN AMCIS Shanghai site clears unannounced NMPA GMP inspection

Successful inspection outcome strengthens company’s regulatory compliance and manufacturing standards in China


Safic-Alcan expands in India with majority stake in SA Ingredients
News | May 07, 2026

Safic-Alcan expands in India with majority stake in SA Ingredients

The deal brings SAI — a key distributor serving pharmaceutical and nutraceutical manufacturers — into the Safic-Alcan Group’s expanding Asia footprint


Venus Remedies gets marketing authorization for Ceftriaxone in Argentina
Drug Approval | May 07, 2026

Venus Remedies gets marketing authorization for Ceftriaxone in Argentina

Approval strengthens the company’s growing international anti-infective portfolio


Practo’s AI-led healthcare marketplace crosses $100 million GMV amid global expansion
Digitisation | May 07, 2026

Practo’s AI-led healthcare marketplace crosses $100 million GMV amid global expansion

Company handles 20,000+ AI-driven calls and chats daily as it scales agentic AI systems across healthcare workflows


Free HLA typing for children with thalassaemia launched in India
Healthcare | May 07, 2026

Free HLA typing for children with thalassaemia launched in India

The initiative by DKMS Foundation India is for below 12 years children suffering from transfusion-dependent thalassemia


China poised to launch world’s first CAR-T therapy for gastric cancer
Biopharma | May 07, 2026

China poised to launch world’s first CAR-T therapy for gastric cancer

As per GlobalData, CARsgen’s satri-cel could mark a major breakthrough in solid tumor treatment as competition intensifies


Alkem Laboratories receives relief as GST demand of Rs 69.65 crore dropped on appeal
News | May 06, 2026

Alkem Laboratories receives relief as GST demand of Rs 69.65 crore dropped on appeal

The company informed stock exchanges that the appellate authority has set aside the GST demand along with applicable interest and penalty


Biocon Biologics receives 5 procedural observations after US FDA inspection at Bengaluru facility
Biopharma | May 06, 2026

Biocon Biologics receives 5 procedural observations after US FDA inspection at Bengaluru facility

The US FDA completed a pre-license inspection of Biocon Biologics’ biosimilars manufacturing site at Biocon Park between April 20 and April 29, 2026


Project Serotonin launches AI-powered gut health protocol
Healthcare | May 06, 2026

Project Serotonin launches AI-powered gut health protocol

The precision health platform integrates genetics, biomarkers, diet, and lifestyle data to deliver personalised gut health interventions and therapy support


PharmEasy launches AI-powered online physiotherapy service
Digitisation | May 06, 2026

PharmEasy launches AI-powered online physiotherapy service

The platform offers personalised recovery plans, AI-driven movement tracking, and access to certified physiotherapists for more than 250 conditions